We first confirmed that gene expression of FOLR1 (for FRα) and of members of the folate signalling pathway (FOLH1, TYMS and DHFR), were elevated in ovarian cancer cell lines and ovarian cancer tissues, compared to normal tissues (Fig. 2 and Supplementary Fig. 1). This evidence concerns the gene TYMS and ovarian carcinoma.